Results 101 to 110 of about 2,937 (121)
Some of the next articles are maybe not open access.

Screening for the lupus anticoagulant

La Ricerca in Clinica e in Laboratorio, 1989
The lupus anticoagulant may be defined as an immunoglobulin (IgG, IgM or both) which interferes with one or more of the in vitro phospholipid-dependent tests of coagulation. For many years, lupus anticoagulants were regarded as a laboratory nuisance; consequently, reagents were often selected on the basis of insensitivity to lupus anticoagulants ...
openaire   +3 more sources

Lupus anticoagulant and chorea

Neurology, 1997
Reply from the Authors: We appreciate Dr. de la Fuente-Fernandez' comments. Our paper suggested that reversible …
Mazen M. Dimachkie   +2 more
openaire   +4 more sources

Monitoring Anticoagulation Therapy in Patients with the Lupus Anticoagulant

JCR: Journal of Clinical Rheumatology, 1998
Patients with a lupus anticoagulant (LAC) may present with thrombosis, and abnormal coagulation studies. It is important to recognize that these individuals may require special laboratory tests other than measuring the activated partial thromboplastin time or prothrombin time/international normalized ratio (PT/INR) traditionally used by clinicians to ...
Kandice Kottke-Marchant   +1 more
openaire   +3 more sources

Lupus Erythematosus and Lupus Anticoagulant

1990
Systemic lupus erythematosus (SLE) occurs primarily in young women, and it often complicates pregnancy. It has been speculated that this autoimmune disorder is so much more common in women than in men (10:1) because of their sensitization to nuclear antigens to which they are exposed during menstruation (Dameshek, 1958; Grimes et al., 1985; Hulka, 1985)
Peter Kaufmann, Kurt Benirschke
openaire   +2 more sources

Anticardiolipin Antibodies and the Lupus Anticoagulant

Annals of Internal Medicine, 1987
Excerpt To the editor: Petri and colleagues (1) have used the antiphospholipid antibody test inappropriately.
Azzudin E. Gharavi, Michael D. Lockshin
openaire   +3 more sources

Procainamide-Induced Lupus Anticoagulant

Southern Medical Journal, 1988
The lupus anticoagulant, with or without other symptoms or signs of lupus, has been described in patients taking procainamide. Screening all such patients for the presence of these anticoagulants may be warranted (despite the rarity of episodes of bleeding) in view of the potentially increased risk of thrombotic events in patients who may already be ...
Heyman Mr   +3 more
openaire   +3 more sources

Mechanisms of activity of lupus anticoagulants

Current Opinion in Hematology, 1997
Lupus anticoagulants comprise a heterogenous group of circulating immunoglobulins that are associated with an increased risk of thrombosis. It was believed earlier that these antibodies were directed against anionic phospholipids. Recent findings, however, establish that the autoantibodies in lupus anticoagulants are not directed against "native ...
openaire   +3 more sources

Lupus Anticoagulant Assays

Seminars in Thrombosis and Hemostasis, 1994
Harry L. Messmore   +4 more
openaire   +3 more sources

Significance of the lupus anticoagulant

American Journal of Hematology, 1986
Robert C. Hartmann, Luis R. Espinoza
openaire   +3 more sources

Detection of lupus anticoagulants

Clinical Reviews in Allergy & Immunology, 1995
M. H. Horellou, M. M. Samama
openaire   +3 more sources

Home - About - Disclaimer - Privacy